Literature DB >> 15389432

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease.

Joseph H Antin1, Allen R Chen, Daniel R Couriel, Vincent T Ho, Richard A Nash, Daniel Weisdorf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15389432     DOI： 10.1016/j.bbmt.2004.07.007

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  13 in total

1.  The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients.

Authors:  Pooja Khandelwal; Julia Lawrence; Alexandra H Filipovich; Stella M Davies; Jacob J Bleesing; Michael B Jordan; Parinda Mehta; Sonata Jodele; Michael S Grimley; Ashish Kumar; Kasiani Myers; Rebecca A Marsh
Journal:  Pediatr Transplant       Date:  2013-10-30

2.  Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial.

Authors:  Marco Mielcarek; Terrence Furlong; Barry E Storer; Margaret L Green; George B McDonald; Paul A Carpenter; Mary E D Flowers; Rainer Storb; Michael Boeckh; Paul J Martin
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

Review 3.  Notch signaling in hematopoietic cell transplantation and T cell alloimmunity.

Authors:  Christen L Ebens; Ivan Maillard
Journal:  Blood Rev       Date:  2013-08-31       Impact factor: 8.250

4.  Graft-versus-host disease treatment: predictors of survival.

Authors:  John E Levine; Brent Logan; Juan Wu; Amin M Alousi; Vincent Ho; Javier Bolaños-Meade; Daniel Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-09       Impact factor: 5.742

Review 5.  Management of acute graft-versus-host disease in children.

Authors:  Paul A Carpenter; Margaret L Macmillan
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

6.  Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease.

Authors:  Akiyoshi Takami; Kanako Mochizuki; Hirokazu Okumura; Satsuki Ito; Yukio Suga; Hirohito Yamazaki; Masahide Yamazaki; Yukio Kondo; Hidesaku Asakura; Shinji Nakao
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

7.  Treatment of Gastrointestinal Acute Graft-Versus-Host Disease.

Authors:  William A Ross
Journal:  Curr Treat Options Gastroenterol       Date:  2005-06

Review 8.  How I treat refractory acute GVHD.

Authors:  H Joachim Deeg
Journal:  Blood       Date:  2007-01-18       Impact factor: 22.113

9.  Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.

Authors:  Marco Mielcarek; Barry E Storer; Michael Boeckh; Paul A Carpenter; George B McDonald; H Joachim Deeg; Richard A Nash; Mary E D Flowers; Kristine Doney; Stephanie Lee; Kieren A Marr; Terry Furlong; Rainer Storb; Frederick R Appelbaum; Paul J Martin
Journal:  Blood       Date:  2008-11-10       Impact factor: 22.113

10.  Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD.

Authors:  A Rager; N Frey; S C Goldstein; R Reshef; E O Hexner; A Loren; S M Luger; A Perl; D Tsai; J Davis; M Vozniak; J Smith; E A Stadtmauer; D L Porter
Journal:  Bone Marrow Transplant       Date:  2010-05-24       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.